Zeroing in on hepatic myofibroblasts while simultaneously addressing the underlying cause(s) of liver damage may be the key to reversing liver fibrosis. A new review by David Brenner, M.D., describes the emerging therapeutic approach.
An accomplished group of early-career researchers including postdoctoral scholars, graduate students and staff scientists showcased their work at Sanford Burnham Prebys’ 22nd Annual Trainee Research Symposium on Thursday, September 21st.
Lukas Chavez, Ph.D., has received $3.2 million from the National Institutes of Health to study how unique DNA circles found in cancer cells drive deadly pediatric brain tumors.
Svasti Haricharan, Ph.D., was the first guest on Stop & Talk—a new podcast offered by The Conrad Prebys Foundation. In the broadcast, Svasti shares how she came to be a research leader in therapy-resistant breast cancer and how race affects clinical outcomes.